Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3272387
Max Phase: Preclinical
Molecular Formula: C22H27NO3
Molecular Weight: 353.46
Molecule Type: Small molecule
Associated Items:
ID: ALA3272387
Max Phase: Preclinical
Molecular Formula: C22H27NO3
Molecular Weight: 353.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Oc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C2CCCCC2)CC[C@@]341
Standard InChI: InChI=1S/C22H27NO3/c24-17-8-6-13-12-16-15-7-9-18(25)21-22(15,19(13)20(17)26-21)10-11-23(16)14-4-2-1-3-5-14/h6-9,14-16,18,21,24-25H,1-5,10-12H2/t15-,16+,18-,21-,22-/m0/s1
Standard InChI Key: NTRNFOZMJHPTHK-HIFDQRORSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 353.46 | Molecular Weight (Monoisotopic): 353.1991 | AlogP: 2.90 | #Rotatable Bonds: 1 |
Polar Surface Area: 52.93 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.86 | CX Basic pKa: 10.72 | CX LogP: 2.21 | CX LogD: 0.14 |
Aromatic Rings: 1 | Heavy Atoms: 26 | QED Weighted: 0.76 | Np Likeness Score: 1.97 |
1. DeGraw JI, Lawson JA, Crase JL, Johnson HL, Ellis M, Uyeno ET, Loew GH, Berkowitz DS.. (1978) Analgesics. 1. Synthesis and analgesic properties of N-sec-alkyl- and N-tert-alkylnormorphines., 21 (5): [PMID:207868] [10.1021/jm00203a002] |
Source(1):